A practical and cost-effective mutation scanning-based approach for investigating genetic variation in Cryptosporidium.
In the present study, we used a mutation scanning-targeted sequencing approach to assess variation in part (pgp60) of the 60 kDa glycoprotein (gp60) gene among Cryptosporidium samples from humans in Victoria, Australia. Two nuclear ribosomal loci (the small subunit rRNA gene and the second internal transcribed spacer) were used to identify the samples as Cryptosporidium hominis (n = 74), Cryptosporidium parvum (n = 23) or Cryptosporidium meleagridis (n = 1). In total, nine distinct pgp60 sequences were identified (three C. hominis, five C. parvum and one C. meleagridis). Phylogenetic analyses of the pgp60 sequence data, employing well-defined reference sequences for comparison, allowed the genotypic and subgenotypic classification of samples. The C. hominis samples were classified as Ib A10G2R2, Id A15G1R2, and a new genotype, designated Ib2, was identified subgenotypically as A18G1R4. The C. parvum samples were classified as IIa A18G3R1, IIa A20G3R1, IIa A22G3R1, IIa A23G3R1 and IIc A5G3R2. These findings suggested that the C. hominis metapopulation is largely homogeneous, consisting of a single dominant genotype, Ib A10G2R2, whereas the C. parvum metapopulation is considerably more heterogeneous, with no single dominant genotype. The greater level of genetic heterogeneity found among the C. parvum samples, despite the smaller sample size, may relate to the zoonotic infection pattern of this species, which would be reflective of a greater number of possible infection sources. The present mutation scanning approach, coupled with targeted sequencing of genetically distinct representatives, is a practical, cost-effective tool for large-scale population genetic and epidemiological studies of Cryptosporidium and other eukaryotic organisms.
Jex
Aaron R
AR
Department of Veterinary Science, The University of Melbourne, Victoria, Australia. ajex@unimelb.edu.au
Whipp
Margaret
M
Campbell
Bronwyn E
BE
Cacciò
Simone M
SM
Stevens
Melita
M
Hogg
Geoff
G
Gasser
Robin B
RB
D000818:Animals; D001315:Australia / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D003457:Cryptosporidiosis / Q000453:epidemiology / Q000235:genetics / Q000469:parasitology; D003458:Cryptosporidium / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification; D016054:DNA, Protozoan / Q000235:genetics / Q000302:isolation & purification; D021903:DNA, Ribosomal Spacer / Q000032:analysis; D016021:Epidemiologic Studies; D005243:Feces / Q000469:parasitology; D005260:Female; D014644:Genetic Variation; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000302:isolation & purification; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D010802:Phylogeny; D018807:Polymorphism, Single-Stranded Conformational / Q000235:genetics*; D015800:Protozoan Proteins / Q000302:isolation & purification; D012680:Sensitivity and Specificity; D017422:Sequence Analysis, DNA / Q000191:economics* / Q000379:methods*; D013045:Species Specificity; D015047:Zoonoses
D016054:DNA, Protozoan; D021903:DNA, Ribosomal Spacer; D008562:Membrane Glycoproteins; D015800:Protozoan Proteins; C448519:S60 glycoprotein, Cryptosporidum parvum